15 / 136
Corporate Identity Serving Diverse Industries Purpose and Values Overview by the Chairman Operational Highlights
Financial Analysis
Research and Technology
Safety, HealthandEnvironment Serving the Society Directors’ Report Management Discussion andAnalysis Report on Corporate Governance Financial Statements
Reserves and Surplus
The reserves and surplus increased by 6% from Rs 429 crores to Rs 455 crores
during the year owing to profit earned.
Loan Funds
The reliance on external funds decreased by 20% from Rs 368 crores to Rs
295 crores due to utilisation of cash generated from operations to repay debts
along with control over working capital levels. Secured loans constituted
88% of the total loans. Of the secured loans, 19% was for funding working
capital requirements; the balance was used in projects. Foreign currency loans
constituted 22% of the total debt. The Company remained reasonably geared
with the ratio of total debt to total equity at 0.56:1.
Applications of Funds
Fixed Assets
Additions to Fixed Assets
During the year, the Company invested Rs 25 crores in Fixed Assets. The
business-wise spends are outlined below:
Business
Rs Crores
Pharmaceuticals and Intermediates
9
Bulk Chemicals and Intermediates
4
Colors
3
Others
9
Depreciation
Depreciation increased by 18% over the previous year, corresponding to the
increase in plant, machinery and building. Cumulative depreciation as a part
of total gross block was 58%.
2005-06
2006-07
2007-08
2008-09
2009-10
Debt-equity ratio
Rs Crores
0.56
1.20
1.17
0.95
0.77
2005-06
2006-07
2007-08
2008-09
2009-10
Reserves and Surplus
Rs Crores
455
243
270
403
429
CAGR 22%